Trifarma is an API manufacturer based in Italy. It holds 20 active US drug master files and one valid CEP across a filed portfolio of 18 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 27 September 2024 as VAI. Customs aggregates show $67K of exports covering 21 molecules to 3 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ceriano Laghetto, Italy | Not on file |
| ROZZANO, Italy | Not on file |
| Italy, Italy | 1000532829 |
| Italy, Italy | 3002807260 |
| ATE, Peru | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Prochlorperazine | US FDA | 3 |
| Fluphenazine | US FDA | 2 |
| Minoxidil | EDQM, US FDA | 2 |
| Clindamycin | US FDA | 1 |
| Clocortolone | US FDA | 1 |
| Epinastine | US FDA | 1 |
| Foscarnet | US FDA | 1 |
| Ganciclovir | US FDA | 1 |
| Halobetasol Propionate | US FDA | 1 |
| Hydrocortisone Valerate | US FDA | 1 |
| Oxandrolone | US FDA | 1 |
| Perphenazine | US FDA | 1 |
| Testosterone | US FDA | 1 |
| Testosterone Cypionate | SFDA (Saudi Arabia) | 1 |
| Thioridazine | US FDA | 1 |
| Tranylcypromine | US FDA | 1 |
| Trifluoperazine | US FDA | 1 |
| Zoledronic Acid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 2 | None |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $5K | 2 |
| 2025 | Not reported | $67K | 3 |
| 2024 | Not reported | $88K | 4 |
| 2023 | Not reported | $455K | 4 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Trifarma comes back tiered against every other supplier able to file there.
Start for free